A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor.
about
The CED-4-homologous protein FLASH is involved in Fas-mediated activation of caspase-8 during apoptosisLFG: an anti-apoptotic gene that provides protection from Fas-mediated cell deathThe prodomain of caspase-1 enhances Fas-mediated apoptosis through facilitation of caspase-8 activationNegative regulation of Fas-mediated apoptosis by FAP-1 in human cancer cellsMST, a physiological caspase substrate, highly sensitizes apoptosis both upstream and downstream of caspase activationInduced expression of PD-1, a novel member of the immunoglobulin gene superfamily, upon programmed cell deathA novel protein that interacts with the death domain of Fas/APO1 contains a sequence motif related to the death domainA cell surface receptor defined by a mAb mediates a unique type of cell death similar to oncosisCytotoxicity-dependent APO-1 (Fas/CD95)-associated proteins form a death-inducing signaling complex (DISC) with the receptorFas-ligand: privilege and perilCaspases are activated in a branched protease cascade and control distinct downstream processes in Fas-induced apoptosisT helper cell activation and human retroviral pathogenesisRole of calmodulin in HIV-potentiated Fas-mediated apoptosisERM (ezrin/radixin/moesin)-based molecular mechanism of microvillar breakdown at an early stage of apoptosisFas involvement in Ca(2+)-independent T cell-mediated cytotoxicityThe effects of chemotherapeutics on cellular metabolism and consequent immune recognitionEstrogen, progesterone and epithelial ovarian cancerExperimental models of hepatotoxicity related to acute liver failurePrinciples of antibody-mediated TNF receptor activationDeath receptor-ligand systems in cancer, cell death, and inflammationGetting TRAIL back on track for cancer therapyA series of Fas receptor agonist antibodies that demonstrate an inverse correlation between affinity and potencySurvivin initiates procaspase 3/p21 complex formation as a result of interaction with Cdk4 to resist Fas-mediated cell deathApoptosis timelineTWEAK, a new secreted ligand in the tumor necrosis factor family that weakly induces apoptosisCauses and consequences of the autoimmune lymphoproliferative syndromeEx vivo pediatric brain tumors express Fas (CD95) and FasL (CD95L) and are resistant to apoptosis inductionPartial tolerance of subcutaneously transplanted xenogeneic tumour cell graft by Fas-mediated immunosuppressionRetinoid-induced apoptosis and Sp1 cleavage occur independently of transcription and require caspase activationBcl-2 and Fas/APO-1 regulate distinct pathways to lymphocyte apoptosisFas- and tumor necrosis factor-induced apoptosis is inhibited by the poxvirus crmA gene productFAS (CD95) mutations are rare in gastric MALT lymphoma but occur more frequently in primary gastric diffuse large B-cell lymphomaFas ligand-independent, FADD-mediated activation of the Fas death pathway by anticancer drugs.Soluble Fas and Fas ligand in human tear fluid after photorefractive keratectomyA functional gene discovery in the Fas-mediated pathway to apoptosis by analysis of transiently expressed randomized hybrid-ribozyme librariesThe evolutionary conservation of the core components necessary for the extrinsic apoptotic signaling pathway, in Medaka fish.Fatty acid synthase: a metabolic enzyme and candidate oncogene in prostate cancer.Elevation of mitochondrial transmembrane potential and reactive oxygen intermediate levels are early events and occur independently from activation of caspases in Fas signalingMany checkpoints on the road to cell death: regulation of Fas-FasL interactions and Fas signaling in peripheral immune responses.ARG098, a novel anti-human Fas antibody, suppresses synovial hyperplasia and prevents cartilage destruction in a severe combined immunodeficient-HuRAg mouse model.
P2860
Q22009525-D53E8377-8328-401C-AEDE-05AD9A2DC130Q22010722-A1B9D54C-79D0-4BF1-BE4F-EC970731ACEFQ22254032-CC8681E8-C93F-4135-834F-43E6C18C3265Q22254697-C3DEA684-C201-459F-83C9-104367DEEA28Q24291002-D8FBA69B-3492-438D-B4D6-DEC14D5102B6Q24293504-C65CFC1E-4736-43CF-A64D-431EB1F8A710Q24306835-23A0015E-6820-4A3B-B5D9-8F35A37DE292Q24319367-D576E90B-A53C-419C-9A41-BCB8B6D6D5DDQ24597543-99F9AF66-3AC6-4E41-A18C-7666BCDF84F5Q24612227-B3CF3687-9BE9-432A-9884-1BC821C7F847Q24647389-2104BC5B-273E-42AE-B8FF-CFCC6DC84330Q24650854-3BE404F6-91AB-4F80-8170-48A1DDF409FBQ24673239-84125D0E-18BD-40DD-A2FB-065486793BC5Q24676652-D9A033A4-952A-49F7-8833-FBB7891CF27CQ24680778-115E97B6-FE52-4619-8C2E-5D869DA97AE9Q24800960-A83ABC15-52FF-49E6-A92F-7D419ACA493BQ24805637-907EA79D-BD7C-4248-90FD-95A89D297B54Q26775293-9EDDFF37-F209-4118-AE39-CC958DA61001Q26796270-75DF5B5A-BE31-4FE0-AEE9-74FF115FA32AQ26865568-8BF56C82-5EBD-4E6F-8625-7373FDA82592Q27027460-72F738AF-B58B-4F30-8745-05C861466176Q27676800-47A502C8-7495-4AF9-8441-E794A62EDB45Q28138374-ED668E9E-A875-46E6-A8F5-8907E1CE96C9Q28215321-D3259B03-9D82-49D5-8A25-7056470A879BQ28257134-02B67DF5-1636-4E0E-B7B7-A2C370A0F07DQ28300792-D0510998-C0BE-49CC-B5F4-1EA5C2DBACF8Q28360990-60E02184-958E-4351-A386-A804DDECCAD7Q28366018-44D285BC-10F2-4A52-8885-9F14D303331BQ28379199-8AB89447-8AA7-4005-BD9F-E827A1EC0A4AQ28588677-17F0AE1C-F85B-4A64-B26F-024C372FD3D2Q28639862-AF6F0B34-5695-4915-950A-101AC46D5DB4Q28767089-B5045BB0-522A-4D98-92AE-791377771469Q30654525-A6688CFD-8377-4A06-B86C-2A4661E6C3BCQ30818743-B8753086-DD5E-4FC3-9942-A80982C56D51Q33184078-B2F53324-B429-45D6-8E3B-14B90D9B72FEQ33286333-FC9E7369-88F8-4A98-8D93-BC7473B23881Q33421665-CDC06046-DCA1-479F-8842-E7B8AF0B07C1Q33608464-9EFD00D8-4457-4245-BEF7-E88DB5070D3FQ33672489-BD24AA39-51B8-48FF-A5E5-033633CA5733Q33704469-67F679A6-90FF-408B-8120-415790919240
P2860
A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor.
description
1989 nî lūn-bûn
@nan
1989 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1989 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1989年の論文
@ja
1989年論文
@yue
1989年論文
@zh-hant
1989年論文
@zh-hk
1989年論文
@zh-mo
1989年論文
@zh-tw
1989年论文
@wuu
name
A cell-killing monoclonal anti ...... ptor of tumor necrosis factor.
@ast
A cell-killing monoclonal anti ...... ptor of tumor necrosis factor.
@en
A cell-killing monoclonal antibody
@nl
type
label
A cell-killing monoclonal anti ...... ptor of tumor necrosis factor.
@ast
A cell-killing monoclonal anti ...... ptor of tumor necrosis factor.
@en
A cell-killing monoclonal antibody
@nl
prefLabel
A cell-killing monoclonal anti ...... ptor of tumor necrosis factor.
@ast
A cell-killing monoclonal anti ...... ptor of tumor necrosis factor.
@en
A cell-killing monoclonal antibody
@nl
P2093
P2860
P356
P1476
A cell-killing monoclonal anti ...... ptor of tumor necrosis factor.
@en
P2093
P2860
P304
P356
10.1084/JEM.169.5.1747
P407
P577
1989-05-01T00:00:00Z